Validation of the Italian version of the PSP Quality of Life questionnaire

Marina Picillo, Sofia Cuoco, Marianna Amboni, Francesco Paolo Bonifacio, Fabio Bruschi, Immacolata Carotenuto, Rosa De Micco, Anna De Rosa, Eleonora Del Prete, Francesca Di Biasio, Francesca Elifani, Roberto Erro, Margherita Fabbri, Marika Falla, Giulia Franco, Daniela Frosini, Sebastiano Galantucci, Giulia Lazzeri, Luca Magistrelli, Maria Chiara MalagutiAnna Vera Milner, Brigida Minafra, Enrica Olivola, Andrea Pilotto, Cristina Rascunà, Maria Cristina Rizzetti, Tommaso Schirinzi, Barbara Borroni, Roberto Ceravolo, Alessio Di Fonzo, Roberta Marchese, Nicola B. Mercuri, Nicola Modugno, Alessandra Nicoletti, Alessandro Padovani, Gabriella Santangelo, Alessandro Stefani, Alessandro Tessitore, Maria Antonietta Volontè, Roberta Zangaglia, Mario Zappia, Maurizio Zibetti, Paolo Barone

Research output: Contribution to journalArticle

Abstract

Background: Progressive supranuclear palsy (PSP) is a rare rapidly progressive, neurodegenerative disease characterized by falls and ocular movement disturbances. The use of health-related quality of life (HR-QoL) measures allows assessing changes in health status induced by therapeutic interventions or disease progress in neurodegenerative diseases. The PSP-QoL is a 45-item, self-administered questionnaire designed to evaluate HR-QoL in PSP. Methods and Results: Here, the PSP-QoL was translated into Italian and validated in 190 PSP (96 women and 94 men; mean age ± standard deviation, 72 ± 6.5; mean disease duration, 4.2 ± 2.3) patients diagnosed according to the Movement Disorder Society criteria and recruited in 16 third level movement disorders centers participating in the Neurecanet project. The mean PSP-QoL total score was 77.8 ± 37 (physical subscore, 46.5 ± 18.7; mental subscore, 33.6 ± 19.2). The internal consistency was high (Cronbach’s alpha = 0.954); corrected item-total correlation was > 0.40 for the majority of items. The significant and moderate correlation of the PSP-QoL with other HR-QoL measures as well as with motor and disability assessments indicated adequate convergent validity of the scale. Gender and geographic location presented a significant impact on the PSP-QoL in our sample with women and patients from the South of Italy scoring higher than their counterparts. Conclusion: In conclusion, the Italian version of the PSP-QoL is an easy, reliable and valid tool for assessment of HR-QoL in PSP.

Original languageEnglish
Pages (from-to)2587-2594
Number of pages8
JournalNeurological Sciences
Volume40
Issue number12
DOIs
Publication statusPublished - Dec 1 2019

Keywords

  • Clinical trials
  • Parkinsonism
  • Progressive supranuclear palsy
  • Quality of life

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Validation of the Italian version of the PSP Quality of Life questionnaire'. Together they form a unique fingerprint.

  • Cite this

    Picillo, M., Cuoco, S., Amboni, M., Bonifacio, F. P., Bruschi, F., Carotenuto, I., De Micco, R., De Rosa, A., Del Prete, E., Di Biasio, F., Elifani, F., Erro, R., Fabbri, M., Falla, M., Franco, G., Frosini, D., Galantucci, S., Lazzeri, G., Magistrelli, L., ... Barone, P. (2019). Validation of the Italian version of the PSP Quality of Life questionnaire. Neurological Sciences, 40(12), 2587-2594. https://doi.org/10.1007/s10072-019-04010-2